How Is Oral Micronized Progesterone Dosed for Luteal Support
Off-label dosing is 200 mg twice daily or 400 mg at bedtime, with moderate evidence supporting outcomes similar to vaginal progesterone in IVF.
Oral Micronized Progesterone: Off-Label Uses
16 source-based articles maintained by the HealthRX.com Editorial Team.
16articles
3topic areas covered
May 25, 2026latest review
Oral Micronized Progesterone: Off-Label Uses library
Showing 16 of 16 clinical reviews.
Micronized Progesterone for Sleep in Menopause: Evidence
Off-label dosing is 100 to 200mg nightly for sleep; evidence is moderate with small RCTs. Includes monitoring steps and dosing guidance.
Oral Micronized Progesterone for Insomnia: Evidence Summary
A clinical evidence review of oral micronized progesterone (Prometrium) used off-label for insomnia, including trial data, dosing, safety, and how it compares to standard sleep aids.
Oral Micronized Progesterone for Insomnia: Monitoring, Evidence, and Off-Label Use
Oral micronized progesterone (Prometrium) is used off-label for insomnia. Learn the evidence, monitoring requirements, dosing, and safety considerations for this sleep aid.
Oral Micronized Progesterone for Insomnia: Off-Label Dosing Protocol
Evidence-based guide to using oral micronized progesterone (Prometrium) off-label for insomnia, including dosing protocols, mechanism of action, clinical evidence, and safety considerations.
Oral Micronized Progesterone for Insomnia: Off-Label Risks and Tradeoffs
Oral micronized progesterone (Prometrium) is used off-label for insomnia due to its GABAergic metabolite allopregnanolone. Learn the evidence, dosing, risks, and how it compares to standard sleep aids.
Oral Micronized Progesterone for Luteal Phase Support
Evidence-based guide to using oral micronized progesterone (Prometrium) off-label for luteal phase support, including dosing, monitoring, and clinical trial data.
Oral Micronized Progesterone for Luteal Phase Support: Evidence Summary
A summary of oral micronized progesterone (Prometrium) used off-label for luteal phase support in ART and natural cycles, covering dosing, evidence quality, and FDA-approved indications.
Oral Micronized Progesterone for Luteal Phase Support: Off-Label Evidence, Risks, and Clinical Tradeoffs
Can oral micronized progesterone (Prometrium) support the luteal phase? Review the off-label evidence, dosing protocols, risks, and how it compares to vaginal and injectable progesterone.
Oral Micronized Progesterone for Perimenopause: Evidence Summary
A clinical evidence summary on using oral micronized progesterone (Prometrium) off-label for perimenopause symptoms including hot flashes, sleep disruption, and irregular bleeding.
Oral Micronized Progesterone for Perimenopause: Off-Label Dosing Protocol
Evidence-based guide to using oral micronized progesterone (Prometrium) off-label for perimenopause symptoms, including dosing protocols, clinical evidence, and safety considerations.
Oral Micronized Progesterone for Perimenopause: Uses, Evidence, and Risks
A clinical deep-dive into off-label oral micronized progesterone (Prometrium) for perimenopause, covering FDA-approved indications, GRADE-rated evidence, dosing, side effects, and when to consider it.
Oral Micronized Progesterone for Traumatic Brain Injury: Evidence Summary
A summary of the evidence for off-label use of oral micronized progesterone (Prometrium) in traumatic brain injury, including ProTECT III, SyNAPSe, GRADE ratings, and current clinical guidance.
Oral Micronized Progesterone for Traumatic Brain Injury: Evidence, Off-Label Status, and Monitoring
A clinical review of oral micronized progesterone (Prometrium) for traumatic brain injury, including Phase III trial failures, off-label considerations, neuroprotective mechanisms, and monitoring protocols.
Oral Micronized Progesterone for Traumatic Brain Injury: Evidence, Risks, and Off-Label Realities
A look at whether oral micronized progesterone (Prometrium) has a role in traumatic brain injury treatment, what the clinical trials found, and the risks patients and providers should weigh.
Oral Micronized Progesterone for Traumatic Brain Injury: Off-Label Dosing Protocol and Evidence Review
Oral micronized progesterone (Prometrium) has been studied for traumatic brain injury neuroprotection. Review the off-label dosing protocols, Phase III trial results from ProTECT III and SyNAPSe, and current evidence grading.